202 related articles for article (PubMed ID: 19602601)
1. Icodextrin metabolites in peritoneal dialysis.
García-López E; Lindholm B
Perit Dial Int; 2009; 29(4):370-6. PubMed ID: 19602601
[No Abstract] [Full Text] [Related]
2. Icodextrin modeling error with PD ADEQUEST, version 2.0.
Amici G; Da Rin G; Bocci C
Perit Dial Int; 2001; 21(5):516-8. PubMed ID: 11757837
[No Abstract] [Full Text] [Related]
3. [Glucose polymer (icodextrin) as a component of fluid for peritoneal dialysis].
Czyzewska K; Szary B; Grzegorzewska A
Pol Arch Med Wewn; 1998 May; 99(5):417-22. PubMed ID: 9816893
[No Abstract] [Full Text] [Related]
4. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
[TBL] [Abstract][Full Text] [Related]
5. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.
Dart A; Feber J; Wong H; Filler G
Pediatr Nephrol; 2005 May; 20(5):683-5. PubMed ID: 15719251
[TBL] [Abstract][Full Text] [Related]
7. Ten years after MIDAS: icodextrin lights and shadows.
Amici G; Da Rin G; Agostini A; Velo S; Bocci C
Contrib Nephrol; 2003; (140):76-81. PubMed ID: 12800346
[No Abstract] [Full Text] [Related]
8. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview.
Floré KM; Delanghe JR
Perit Dial Int; 2009; 29(4):377-83. PubMed ID: 19602602
[TBL] [Abstract][Full Text] [Related]
9. Potential hazards of polyglucose.
Diaz-Buxo JA; Passlick-Deetjen J; Gotloib L
ASAIO J; 2001; 47(6):602-7. PubMed ID: 11730195
[No Abstract] [Full Text] [Related]
10. Initial experience with icodextrin in Indian patients.
Bhowmik D; Khaira A; Mahajan S; Tiwari SC
Perit Dial Int; 2007; 27(4):467-8. PubMed ID: 17602160
[No Abstract] [Full Text] [Related]
11. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
12. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
Qi H; Xu C; Yan H; Ma J
Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
[TBL] [Abstract][Full Text] [Related]
13. The variability in ultrafiltration achieved with icodextrin, possibly explained.
Venturoli D; Jeloka TK; Ersoy FF; Rippe B; Oreopoulos DG
Perit Dial Int; 2009; 29(4):415-21. PubMed ID: 19602607
[TBL] [Abstract][Full Text] [Related]
14. Icodextrin: an alternative peritoneal dialysis fluid.
Chhabra D; Nash K
Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1455-64. PubMed ID: 18950286
[TBL] [Abstract][Full Text] [Related]
15. Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.
Parra MA; Campanero MA; Sádaba B; Irigoyen A; García-López L; Fernandez-Reyes MJ; Azanza JR
Perit Dial Int; 2013; 33(4):458-61. PubMed ID: 23843594
[No Abstract] [Full Text] [Related]
16. Icodextrin: a review of its use in peritoneal dialysis.
Frampton JE; Plosker GL
Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of peritoneal fluid and solute transport with combination of glucose and icodextrin as osmotic agents.
Galach M; Werynski A; Waniewski J; Freida P; Lindholm B
Perit Dial Int; 2009; 29(1):72-80. PubMed ID: 19164256
[TBL] [Abstract][Full Text] [Related]
18. The icodextrin black line sign.
Robertson S; Huxtable H; Blakemore C; Williams G; Donovan KL
Perit Dial Int; 2001; 21(6):621-3. PubMed ID: 11783776
[No Abstract] [Full Text] [Related]
19. [Glucose polymer in the long dwell exchanges in peritoneal dialysis--advantages and limitations].
Olszowska A
Pol Merkur Lekarski; 2008 Apr; 24(142):355-8. PubMed ID: 18634373
[TBL] [Abstract][Full Text] [Related]
20. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
Jenkins SB; Wilkie ME
Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
